Pulmonary arterial hypertension is a rare disease of the pulmonary vasculature,
characterised pathologically by proliferation, remodelling and thrombosis in situ …

Pulmonary arterial hypertension is a multifactorial disease characterized by
vasoconstriction, vascular remodeling, inflammation and thrombosis. Although an increasing …

The last 10 years have seen significant advances in the understanding of the
pathophysiology and treatment of pulmonary arterial hypertension (PAH). This has included …

Thrombosis and platelet dysfunction are potentially important pathophysiologic processes
that have been identified from descriptive studies from patients with pulmonary arterial …

Clinical and translational research has played a major role in advancing our understanding
of pulmonary hypertension (PH), including pulmonary arterial hypertension and other forms …

Pulmonary hypertension (PH) is a complex, multifactorial disorder divided into five major
subtypes according to pathological, pathophysiological and therapeutic characteristics …

Pulmonary Hypertension (PH) is a multifactorial and lethal disease, characterised by
elevated pulmonary arterial pressure and progressive right heart failure. PH pathobiology …

Highlights•Thrombosis and excess platelet activation are key pathologic features of
pulmonary arterial hypertension (PAH).•Platelets are the main source of circulating …

Pulmonary hypertension is defined as an increase of the mean pulmonary arterial pressure
above 25 mm Hg and, as such, the diagnosis requires invasive haemodynamic …

Simple Summary This review discusses the role of extracellular vesicles in pulmonary
hypertension a serious and progressive lung disease characterized by high blood pressure …